China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHIFree Report) in a report released on Sunday. The firm issued a hold rating on the stock.

China Pharma Stock Down 6.9 %

Shares of China Pharma stock opened at $0.25 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. The business has a 50-day moving average of $0.23 and a two-hundred day moving average of $0.22. China Pharma has a 1 year low of $0.13 and a 1 year high of $0.41.

About China Pharma

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Recommended Stories

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.